We observed that knocking down TDP2 significantly inhibited the migration ability of prostate cancer cells, while overexpression of TDP2 significantly enhanced the migration ability (Figs 3E, 3F, S2A and S2B). Here, TDP2 is linked to prostate carcinoma.